These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22052996)

  • 1. Inhibitory effects of native and recombinant full-length camel lactoferrin and its N and C lobes on hepatitis C virus infection of Huh7.5 cells.
    Liao Y; El-Fakkarany E; Lönnerdal B; Redwan EM
    J Med Microbiol; 2012 Mar; 61(Pt 3):375-383. PubMed ID: 22052996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus.
    Redwan EM; El-Fakharany EM; Uversky VN; Linjawi MH
    BMC Complement Altern Med; 2014 Jul; 14():219. PubMed ID: 24993815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study.
    El-Fakharany EM; Sánchez L; Al-Mehdar HA; Redwan EM
    Virol J; 2013 Jun; 10():199. PubMed ID: 23782993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7.5 hepatoma.
    El-Fakharany EM; Abedelbaky N; Haroun BM; Sánchez L; Redwan NA; Redwan EM
    Virol J; 2012 Sep; 9():201. PubMed ID: 22978304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Exploration of the Anti-HCV Potential of the Synthetic Spacer Peptides Derived from Human, Bovine, and Camel Lactoferrins.
    Albar AH; El-Fakharany EM; Almehdar HA; Uversky VN; Redwan EM
    Protein Pept Lett; 2017; 24(10):909-921. PubMed ID: 27834141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes.
    Abe K; Nozaki A; Tamura K; Ikeda M; Naka K; Dansako H; Hoshino HO; Tanaka K; Kato N
    Microbiol Immunol; 2007; 51(1):117-25. PubMed ID: 17237607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes.
    Redwan el-RM; Tabll A
    J Immunoassay Immunochem; 2007; 28(3):267-77. PubMed ID: 17613672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes.
    Ikeda M; Sugiyama K; Tanaka T; Tanaka K; Sekihara H; Shimotohno K; Kato N
    Biochem Biophys Res Commun; 1998 Apr; 245(2):549-53. PubMed ID: 9571193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reliable internally controlled RT-nested PCR method for the detection of hepatitis C virus RNA.
    Nozaki A; Naganuma A; Nakamura T; Tanaka K; Sekihara H; Kato N
    Acta Med Okayama; 2000 Dec; 54(6):253-7. PubMed ID: 11132918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells.
    Ikeda M; Nozaki A; Sugiyama K; Tanaka T; Naganuma A; Tanaka K; Sekihara H; Shimotohno K; Saito M; Kato N
    Virus Res; 2000 Jan; 66(1):51-63. PubMed ID: 10653917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein.
    Nozaki A; Ikeda M; Naganuma A; Nakamura T; Inudoh M; Tanaka K; Kato N
    J Biol Chem; 2003 Mar; 278(12):10162-73. PubMed ID: 12522210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aloperine inhibits hepatitis C virus entry into cells by disturbing internalisation from endocytosis to the membrane fusion process.
    Lv XQ; Zou LL; Tan JL; Li H; Li JR; Liu NN; Dong B; Song DQ; Peng ZG
    Eur J Pharmacol; 2020 Sep; 883():173323. PubMed ID: 32622669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate enhances poly I:C-induced interferon-λ1 production and inhibits hepatitis C virus replication in hepatocytes.
    Wang YZ; Li JL; Wang X; Zhang T; Ho WZ
    World J Gastroenterol; 2017 Aug; 23(32):5895-5903. PubMed ID: 28932081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humanized-VH/VHH that inhibit HCV replication by interfering with the virus helicase activity.
    Phalaphol A; Thueng-In K; Thanongsaksrikul J; Poungpair O; Bangphoomi K; Sookrung N; Srimanote P; Chaicumpa W
    J Virol Methods; 2013 Dec; 194(1-2):289-99. PubMed ID: 24036073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
    Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
    Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tannic Acid Inhibits Hepatitis C Virus Entry into Huh7.5 Cells.
    Liu S; Chen R; Hagedorn CH
    PLoS One; 2015; 10(7):e0131358. PubMed ID: 26186636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mouse monoclonal antibody towards e1 specific epitope blocks viral entry and intracellular viral replication in vitro.
    Tabll AA; Moustafa RI; El Abd YS; Bader El Din NG; El-Shenawy R; Yousef H; Hussein M; Dawood RM; Omran MH; El-Awady MK
    J Immunoassay Immunochem; 2014; 35(1):60-73. PubMed ID: 24063617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticosteroids increase cell entry by hepatitis C virus.
    Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
    Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.